Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11932361rdf:typepubmed:Citationlld:pubmed
pubmed-article:11932361lifeskim:mentionsumls-concept:C0032854lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C1518999lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C0205851lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C0439659lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C1317973lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C0183683lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C0344211lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C1521721lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C0085973lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C0007320lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C1561558lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C2348628lld:lifeskim
pubmed-article:11932361lifeskim:mentionsumls-concept:C1171411lld:lifeskim
pubmed-article:11932361pubmed:issue1lld:pubmed
pubmed-article:11932361pubmed:dateCreated2002-4-4lld:pubmed
pubmed-article:11932361pubmed:abstractTextA variety of regimens of high-dose chemotherapy with hematopoietic stem cell support for poor risk germ cell tumors have been established. However, a series of chemotherapy steps carried out prior to the harvest sometimes leads to an insufficient number of peripheral blood stem cells. Here, we report a case of a patient who successfully underwent high-dose chemotherapy for the treatment of poor risk extragonadal germ cell tumor by receiving peripheral blood stem cell transplantation donated from his genomically identical twin brother.lld:pubmed
pubmed-article:11932361pubmed:languageenglld:pubmed
pubmed-article:11932361pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11932361pubmed:citationSubsetIMlld:pubmed
pubmed-article:11932361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11932361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11932361pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11932361pubmed:statusMEDLINElld:pubmed
pubmed-article:11932361pubmed:monthJanlld:pubmed
pubmed-article:11932361pubmed:issn0368-2811lld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:OgawaOsamuOlld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:KobayashiTaka...lld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:KakehiYoshiyu...lld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:YamamotoShing...lld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:NakamuraEijir...lld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:KamatoToshiyu...lld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:ItoNoriyukiNlld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:FukuyamaTakuo...lld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:HishizawaMasa...lld:pubmed
pubmed-article:11932361pubmed:authorpubmed-author:IchinoheTatsu...lld:pubmed
pubmed-article:11932361pubmed:issnTypePrintlld:pubmed
pubmed-article:11932361pubmed:volume32lld:pubmed
pubmed-article:11932361pubmed:ownerNLMlld:pubmed
pubmed-article:11932361pubmed:authorsCompleteYlld:pubmed
pubmed-article:11932361pubmed:pagination33-4lld:pubmed
pubmed-article:11932361pubmed:dateRevised2006-4-24lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:meshHeadingpubmed-meshheading:11932361...lld:pubmed
pubmed-article:11932361pubmed:year2002lld:pubmed
pubmed-article:11932361pubmed:articleTitleDose-intensive chemotherapy with syngeneic peripheral blood stem cell support for poor risk germ cell tumor of extragonadal origin: a case report.lld:pubmed
pubmed-article:11932361pubmed:affiliationDepartment of Urology, Kyoto University Hospital, Kyoto, Japan.lld:pubmed
pubmed-article:11932361pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11932361pubmed:publicationTypeCase Reportslld:pubmed